Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yu Chen Pei"'
Autor:
Xi Yu, Qi-Zhi Liang, Jun-Long Wang, Yu-chen Pei, Jian-Peng Cai, Liu-Hua Chen, Qi Liu, Tian Lan, Wei Chen, Li-Jian Liang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Surgical therapy is the most optimal treatment for hepatocellular carcinoma (HCC) combined with bile duct tumor thrombus (BDTT) patients. However, whether to perform bile duct resection (BDR) is still controversial. The purpose of
Externí odkaz:
https://doaj.org/article/9ff8c7c2b0ee4bf8a3b16afd7dcd6468
Autor:
Chao Chen, Cai-Jin Lin, Yu-Chen Pei, Ding Ma, Li Liao, Si-Yuan Li, Lei Fan, Gen-Hong Di, Song-Yang Wu, Xi-Yu Liu, Yun-Jin Wang, Qi Hong, Guo-Liang Zhang, Lin-Lin Xu, Bei-Bei Li, Wei Huang, Jin-Xiu Shi, Yi-Zhou Jiang, Xin Hu, Zhi-Ming Shao
Publikováno v:
Cell Discovery, Vol 9, Iss 1, Pp 1-22 (2023)
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but their role in breast cancer, especially in non-Caucasians, remains poorly characterized. We performed large-scale prospective targeted sequencing of
Externí odkaz:
https://doaj.org/article/e84cc79299584a45a1cc58c8e60cfc41
Autor:
Guan-Tian Lang, Yi-Zhou Jiang, Jin-Xiu Shi, Fan Yang, Xiao-Guang Li, Yu-Chen Pei, Chen-Hui Zhang, Ding Ma, Yi Xiao, Peng-Chen Hu, Hai Wang, Yun-Song Yang, Lin-Wei Guo, Xun-Xi Lu, Meng-Zhu Xue, Peng Wang, A-Yong Cao, Hong Ling, Zhong-Hua Wang, Ke-Da Yu, Gen-Hong Di, Da-Qiang Li, Yun-Jin Wang, Ying Yu, Le-Ming Shi, Xin Hu, Wei Huang, Zhi-Ming Shao
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Chinese breast cancer patients have not been well represented in clinical sequencing studies. Here the authors analyse the mutational landscape of 1,134 Chinese breast cancer patients, finding actionable targets and a higher prevalence of p53 and Hip
Externí odkaz:
https://doaj.org/article/61dd0a122435489e99726b2dc7d128dc
Autor:
Xun-Xi Lu, Wen-Xiao Yang, Yu-Chen Pei, Hong Luo, Xiaoguang Li, Yun-Jin Wang, Guo-Liang Zhang, Hong Ling, Zhiming Shao, Xin Hu
Publikováno v:
Cancer Research.
Dysregulation of RNA-binding proteins (RBPs) is one of the characteristics of cancer. Investigating the biological functions and molecular mechanisms of abnormal RBPs can help uncover new cancer biomarkers and treatment strategies. To identify oncoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0e9e848910053fbbcb46baa42db9458
https://doi.org/10.1158/0008-5472.can-22-0536
https://doi.org/10.1158/0008-5472.can-22-0536
Autor:
Peng Ji, Yue Gong, Ming-liang Jin, Huai-liang Wu, Lin-Wei Guo, Yu-Chen Pei, Wen-Jun Chai, Yi-Zhou Jiang, Yin Liu, Xiao-Yan Ma, Gen-Hong Di, Xin Hu, Zhi-Ming Shao
Publikováno v:
Science Advances. 8
Immune checkpoint inhibitors exhibit limited response rates in patients with triple-negative breast cancer (TNBC), suggesting that additional immune escape mechanisms may exist. Here, we performed two-step customized in vivo CRISPR screens targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efc180a2bd79809319390166da8e7339
https://doi.org/10.1126/sciadv.abl8247
https://doi.org/10.1126/sciadv.abl8247
Autor:
Mengzhu Xue, Leming Shi, Xun-Xi Lu, Zhi-Ming Shao, Gen-Hong Di, Lin-Wei Guo, Yi Xiao, Ying Yu, Zhong-Hua Wang, Guan-Tian Lang, Wei Huang, Fan Yang, A-Yong Cao, Yun-Song Yang, Shi Jinxiu, Peng Wang, Hai Wang, Yu-Chen Pei, Xiao-Guang Li, Peng-Chen Hu, Xin Hu, Hong Ling, Ke-Da Yu, Ding Ma, Yun-Jin Wang, Yi-Zhou Jiang, Chen-Hui Zhang, Da-Qiang Li
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Nature Communications
Nature Communications
The remarkable advances in next-generation sequencing technology have enabled the wide usage of sequencing as a clinical tool. To promote the advance of precision oncology for breast cancer in China, here we report a large-scale prospective clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de4051500e160cbc5a581b02ac200682
https://doaj.org/article/61dd0a122435489e99726b2dc7d128dc
https://doaj.org/article/61dd0a122435489e99726b2dc7d128dc
Publikováno v:
Key Engineering Materials. 861:165-169
3D printed carbon fiber reinforced composites (CFRP) have shown great potential in lightweight application. Here, we report a prepreg carbon fiber reinforced polyamide composite by fused filament fabrication 3D printing process. The influence of laye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f25fe7c6809df8459d7038961d4ce6d4
https://doi.org/10.4028/www.scientific.net/kem.861.165
https://doi.org/10.4028/www.scientific.net/kem.861.165
Autor:
Yun-Jin Wang, Xun-Xi Lu, Yu-Chen Pei, Xin Hu, Hong Ling, Lin-Wei Guo, Yue Gong, Xiang-Chen Han, Xiao-Guang Li, Bo-yue Han
Background Distant metastases are the leading cause of death among breast cancer (BC) patients, and lung is the second preferential colonized sits. However, there has been no prognostic evaluation of BC patients with lung metastases so far. This rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb87c04478d3f7290c6a152b2c2fe068
https://doi.org/10.21203/rs.3.rs-255801/v1
https://doi.org/10.21203/rs.3.rs-255801/v1
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer
Autor:
Ding Ma, Guangyu Liu, Si-Yu Chen, Xiao-En Xu, Da-Qiang Li, Yi-Zhou Jiang, Yi Xiao, Yu-Chen Pei, Xin Hu, Zhi-Ming Shao, Xiao-Zhen Liang, Jin-Xiao Ren, Ke-Da Yu, Shen Zhao, Cong-Wei Jiang
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background The germline variant spectrum of triple-negative breast cancer (TNBC) is different from that of other subtypes and has demonstrated ethnic differences. However, the germline variants of TNBC among Chinese patients and its clinical signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::449e973ff9bdf346cfc87be9f7bff661
https://doi.org/10.1093/jnci/djaa175
https://doi.org/10.1093/jnci/djaa175
Autor:
Xiao-Guang Li, Zhi-Ming Shao, Mengzhu Xue, Yi-Zi Zheng, Feng Qiao, Yu-Chen Pei, Yi-Zhou Jiang, Min He, Xi-Yu Liu, Wei-Li Sun, Bi Lian, Xin Hu, Da-Qiang Li, Hong Ling, Ling Yao
Publikováno v:
Theranostics
Rationale: Paclitaxel resistance is a major concern when treating triple-negative breast cancer (TNBC) patients. We aimed to identify candidates causing paclitaxel resistance and explore their significance in TNBC therapeutics. Methods: A genome-wide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f216abc1f8d7277609adefd214a6f484
https://pubmed.ncbi.nlm.nih.gov/33042272
https://pubmed.ncbi.nlm.nih.gov/33042272